Raynaud's Syndrome in a Patient Treated with Milnacipran

Sanders-Bush E Mayer SE . 5-Hydroxytryptamine (serotonin) receptor agonists and antagonists. In: Hardman JG Limbird LE Molinott PB Ruddon RW Gilman AG , eds. Goodman & Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill, 1996: 254–5.

Biondi ML Marasini B Bianchi E . Plasma free and intraplatelet serotonin in patients with Raynaud's phenomenon. Int J Cardiol 1988;19: 335–9.

Bel C Coupland N Creamer P . Digital infarction in a patient with Ray-naud's phenomenon associated with treatment with a specific serotonin reuptake inhibitor — a case report. Angiology 1996;47: 901–3.

Rudnick A Modai I Zelikovski A . Fluoxetine-induced Raynaud's phenomenon. Biol Psychiatry 1997;41: 1218–21.

Celada P Dolera M Alvarez E Artigas F . Effects of acute and chronic treatment with fluvoxamine on extracellular and platelet serotonin in the blood of major depressive patients. Relationship to clinical improvement. J Affect Disord 1992;25: 243–50.

Jaffe IA . Serotonin reuptake inhibitors in Raynaud's phenomenon (letter). Lancet 1995;345:1378.